Nevada Tech Journal
SEE OTHER BRANDS

Your science and technology news from Nevada

Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on June 23, 2025

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

How Parkinson’s affects million – and why current treatments are not enough Continuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson’s care Serina’s drug candidate SER-252 is designed to deliver continuous symptom relief Join Serina CEO …

WISeKey’s Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications

WISeKey’s Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications

Courtesy of SpaceX WISeKey’s Subsidiaries WISeSat and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space and Advancing Quantum-Safe Space Communications SEALSQ and WISeSat are setting the foundation for a new generation of …

WISeSat.Space and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space, and Advancing Quantum-Safe Space Communications

WISeSat.Space and SEALSQ Launch New Satellite with SpaceX, Enabling the First-Ever DePIN from Space, and Advancing Quantum-Safe Space Communications

Geneva, Switzerland, June 23, 2025 (GLOBE NEWSWIRE) -- Courtesy of SpaceX SEALSQ and WISeSat are setting the foundation for a new generation of cyber-resilient, quantum-ready space systems, redefining global digital trust from orbit SEALSQ Corp (NASDAQ: …

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders

TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of …

Acceleware Announces Strategic Collaboration and Distribution Agreement with Scovan

Acceleware Announces Strategic Collaboration and Distribution Agreement with Scovan

CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (RF) power-to-heat technologies targeting process heat for critical minerals, amine …

Red Earth Casino Chooses QCI Chatalytics to Enhance Casino Operations with Integrated AI Solutions

Red Earth Casino Chooses QCI Chatalytics to Enhance Casino Operations with Integrated AI Solutions

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Red Earth Casino has chosen Quick Custom Intelligence’s (QCI) Chatalytics platform to revolutionize its casino operations and elevate guest engagement. This AI-powered suite—which includes Slot Copilot, Player …

Lucas GC Limited Announces Closing of Follow-On Offering

Lucas GC Limited Announces Closing of Follow-On Offering

NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Lucas GC Limited (NASDAQ: LGCL) (“Lucas” or the “Company”), an artificial intelligence (“AI”) technology-driven Platform-as-a-Service (“PaaS”) company with proprietary technologies applied to the human resources …

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

Lyell Immunopharma to Participate in the H.C. Wainwright “HCW@Home” Series

SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management …

QFSCOIN launches free Bitcoin cloud mining option compliant with US SEC regulation

QFSCOIN launches free Bitcoin cloud mining option compliant with US SEC regulation

Dover, DE, June 23, 2025 (GLOBE NEWSWIRE) -- Dogecoin (DOGE) just got another jolt of excitement. After Elon Musk dropped a casual but powerful hint about incorporating Dogecoin into the X Payments platform, the meme coin saw a sharp 7% price jump  …

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…

Scilex Holding Company Announces Deferral of Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from May 2, 2025 to…

PALO ALTO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

Liquidia Receives $50 Million from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA™

MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced the receipt of an additional $50.0 million …

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for ROMVIMZA™ (vimseltinib)

LOUISVILLE, Ky., June 23, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent specialty pharmacy, has been selected as a specialty pharmacy partner by Deciphera Pharmaceuticals, LLC for ROMVIMZA™ (vimseltinib), which has been approved by …

Cidara Announces Proposed Public Offering of Common Stock

Cidara Announces Proposed Public Offering of Common Stock

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an …

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

Natural Alternatives International, Inc. Announces Amended and Extended Credit Facility with Wells Fargo Bank

CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit …

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

iBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference Call

Review of promising Myostatin and Activin E antibody data iBio to announce 3rd target in Astral Bio Collaboration Conference call Tuesday, June 24 at 8:30 a.m. ET SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven …

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Terns Pharmaceuticals Presents Positive Data from Phase 1 Study of TERN-601 Once-daily Oral GLP-1R Agonist for Treatment of Obesity at 85th Annual American Diabetes Association Scientific Sessions

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in September 2024 Phase 2 FALCON clinical trial of TERN-601 completed enrollment; 12-week data expected in 4Q 2025 FOSTER CITY, Calif., June …

dLocal announces appointment of Independent Board Member

dLocal announces appointment of Independent Board Member

MONTEVIDEO, Uruguay, June 23, 2025 (GLOBE NEWSWIRE) -- DLocal Limited (“dLocal”, “we”, “us”, and “our”) (NASDAQ:DLO), a technology-first payments platform, today announced the appointment of Will Pruett as an Independent Board Member and well as a member …

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …

iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

iMDx Reports Strong Head-to-Head Data in Kidney Transplant Rejection Testing

Study indicates iMDx flagship technology’s equivalence with commercially available dd-cfDNA test kits Head-to-head comparison of iMDx’s digital PCR-based test kits with NGS kits shows consistent results in 96 transplant patients Data was presented at the …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service